Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Aurinia Pharmaceuticals Inc
AUPH | US
14.37
USD0.05
0.35%
AUPH | US
Loading StockChartView...
About Aurinia Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
14.37
Open
14.24
High
14.50
Low
14.01
Aurinia Pharmaceuticals Inc. a commercial-stage biopharmaceutical company focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. The company also offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co. Ltd. Aurinia Pharmaceuticals Inc. is headquartered in Victoria Canada.
View LessAUPH | US
Risk
32.7
Sharpe
1.58
Luna's Score
69/100
Recommendation
Buy
Luna says (AUPH | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
High Short-term Volatility
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
44.0%1 month
32.7%3 months
29.9%6 months
43.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
15.15
Price to book
2.82
Debt to equity
0.24
Debt to assets
0.16
Ent. to EBITDA
-7.69
Ent. to rev.
3.78
PEG
-
Other Fundamentals
EBITDA
-27.15M
MarketCap
2.05B
MarketCap(USD)
2.05B
Div. yield
-
Op. margin
-0.77
Erngs. growth
-
Rev. growth
37.80
Ret. on equity
-13.30
Short ratio
5.52
Short perc.
5.09
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.72
Range1M
1.72
Range3M
3.02
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.33
Price X volume
19.46M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -7.69 | 0.53 | Cheaper |
| Ent. to Revenue | 3.78 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.82 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 29.95 | 72.80 | Lower Risk |
| Debt to Equity | 0.24 | -1.23 | Expensive |
| Debt to Assets | 0.16 | 0.25 | Cheaper |
| Market Cap | 2.05B | 3.66B | Emerging |
